MedTrace Logo

Treatment of Atrial Fibrillation in Finland

NCT01990105 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1013

Last updated 2015-03-09

No results posted yet for this study

Summary

FINFIB 2 is an observational investigator-driven study that seeks to examine current treatment practice for atrial fibrillation in Finland. The investigators hypothesis is that the treatment of atrial fibrillation has improved since the introduction of new antiarrhythmic drugs and anticoagulants.

Conditions

Sponsors & Collaborators

  • Helsinki University Central Hospital

    collaborator OTHER

  • Kuopio University Hospital

    collaborator OTHER

  • Oulu University Hospital

    collaborator OTHER

  • Tampere University Hospital

    collaborator OTHER

  • Turku University Hospital

    collaborator OTHER_GOV

  • Finnish Cardiac Society

    lead OTHER

Principal Investigators

  • Pekka Raatikainen, MD, PhD · Heart Center Tampere Univerisity Hospital

  • Juha Hartikainen, MD · Kuopio University Hospital

  • Timo Lauri, MD · Oulu University Hospital

  • Mika Lehto, MD · Helsinki University Central Hospital

  • Markku Mäkijärvi, MD · Helsinki University Central Hospital

  • Juha Lund, MD · Turku University Hospital

  • Heikki Mäkynen, MD · Heart Center Tampere University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2013-11-30
Completion
2014-04-30

Countries

  • Finland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01990105 on ClinicalTrials.gov